1st Onco Icons Award on the occasion of Int. Women’s Day, 8th March’24
02/06/2024Jenphar SPD hosted an Award show titled “Onco Icons Award” which was first of its kind on the occasion of…Jenphar Bangladesh Ltd. emerges as a Green Champion
03/05/2024Jenphar was recognized as a “Green Champion” for their collaborative efforts with Mutual Trust Bank PLC in implementing Climate Mitigation…
Olaparib Tablet makes historic debut in Sri Lanka, Revolutionizing Cancer Treatment Landscape
25/06/2023Jenphar Bangladesh Limited has achieved a remarkable milestone by registering its groundbreaking oncology product Olaparib INN Tablet (Juparib 100 mg…Jenphar has stepped up in the oncology market with a new option for Breast Cancer
25/06/2023Jenphar Bangladesh Limited, has stepped up in the oncology market with its new product HER-2N 200 tablet, preparation of Ribociclib…Jenphar has launched new oncology brand for Sarcoma & kidney Cancer
25/06/2023Jenphar Bangladesh Limited is pleased to announce the successful launch of new oncology product Pazopanib Hydrochloride 400 mg tablet as…Jenphar Bangladesh achieves GMP Certificate from Ministry of Health (MOH), Syria
25/06/2023Jenphar manufacturing site, a state of art facility achieves a triumph by registering their company in Syria which has opened…
Blood Donation Program
25/06/2023
